THOMAS N DARLING, M.D. PH.D.
Dermatology at Jones Bridge Rd, Bethesda, MD

License number
Maryland 36508
Category
Osteopathic Medicine
Type
Dermatology
Address
Address 2
4301 Jones Bridge Rd, Bethesda, MD 20814
2 Lochness Ct, Rockville, MD 20850
Phone
(301) 295-3528
(301) 295-3150 (Fax)
(301) 762-4697

Personal information

See more information about THOMAS N DARLING at radaris.com
Name
Address
Phone
Thomas Darling, age 63
2 Lochness Ct, Rockville, MD 20850
(301) 762-4697
Thomas Darling
800 Ivy League Ln, Rockville, MD 20850
(301) 762-4697
Thomas Darling, age 56
130 Francis Dr, Salisbury, MD 21804
Thomas Darling, age 68
1760 Shaftsbury Ave, Crofton, MD 21114
(410) 451-2826

Professional information

See more information about THOMAS N DARLING at trustoria.com
Thomas Noel Darling Photo 1
Thomas Noel Darling, Bethesda MD

Thomas Noel Darling, Bethesda MD

Specialties:
Dermatologist
Address:
4301 Jones Bridge Rd, Bethesda, MD 20814
Education:
Doctor of Medicine
Board certifications:
American Board of Dermatology Certification in Dermatology


Thomas N Darling Photo 2
Dr. Thomas N Darling, Bethesda MD - MD (Doctor of Medicine)

Dr. Thomas N Darling, Bethesda MD - MD (Doctor of Medicine)

Specialties:
Dermatology
Address:
4301 Jones Bridge Rd, Bethesda 20814
(301) 295-3528 (Phone), (301) 295-3150 (Fax)
Certifications:
Dermatology, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Duke University
Graduated: 1990


Thomas Darling Photo 3
Hair Follicle Neogenesis

Hair Follicle Neogenesis

US Patent:
2013020, Aug 15, 2013
Filed:
Jun 17, 2011
Appl. No.:
13/704431
Inventors:
Rajesh Thangapazham - Rockville MD, US
Thomas N. Darling - Rockville MD, US
Shaowei Li - Potomac MD, US
International Classification:
A61L 27/38, A61L 27/60
US Classification:
424 9321, 424 937
Abstract:
This invention provides a skin substitute comprising epithelial cells and modified mesenchymal cells, wherein the modified mesenchymal cells have decreased TSC1/TSC2 function, increased mTORCI function, and/or decreased mTORC2 function compared to wild type mesenchymal cells, and methods for using the same. This invention also provides a method for transplanting cells capable of inducing hair follicles, comprising subdermally or intradermally delivering to a patient modified mesenchymal cells, wherein the modified mesenchymal cells have decreased TSC1/TSC2 function, increased mTORCI function, and/or decreased mTORC2 function compared to wild type mesenchymal cells.